Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4929715 | Asian Journal of Psychiatry | 2017 | 27 Pages |
Abstract
Despite enhanced treatment adherence and potential to lower risk of rehospitalizations from relapse, LAIs are not the preferred treatment choice for patients with schizophrenia in India, owing to their perceived high costs.
Keywords
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Prasad Rao Gundugurti, Rajesh Nagpal, Ashit Sheth, Prashant Narang, Sonal Gawande, Vikram Singh,